CEREBRAL SMALL VESSEL DISEASES
Clinical trials for CEREBRAL SMALL VESSEL DISEASES explained in plain language.
Never miss a new study
Get alerted when new CEREBRAL SMALL VESSEL DISEASES trials appear
Sign up with your email to follow new studies for CEREBRAL SMALL VESSEL DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Herbal capsule may slow brain vessel damage in hypertension patients
Disease control Not yet recruitingThis study tests whether Songling Xuemaikang capsules can help control cerebral small vessel disease (CSVD), a condition where tiny blood vessels in the brain get damaged over time, often linked to high blood pressure. Researchers will enroll 90 adults aged 55-75 with high blood …
Matched conditions: CEREBRAL SMALL VESSEL DISEASES
Phase: NA • Sponsor: Dongzhimen Hospital, Beijing • Aim: Disease control
Last updated May 26, 2026 02:54 UTC
-
New combo therapy aims to cut stroke disability in half
Disease control Not yet recruitingThis study tests whether two drugs, isosorbide mononitrate and butylphthalide, can reduce disability in people who recently had a lacunar (small vessel) stroke. About 3,156 adults aged 30 and older will take one or both drugs for up to a year. The goal is to see if these treatmen…
Matched conditions: CEREBRAL SMALL VESSEL DISEASES
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Herbal hope: new pill aims to stop second strokes in brain bleed survivors
Disease control Not yet recruitingThis study tests whether Naoxuekang Dropping Pills, a Chinese herbal medicine, can reduce the risk of future strokes, heart attacks, or blood clots in people who recently had a brain bleed caused by high blood pressure. About 1,950 adults will receive either the herbal pill or a …
Matched conditions: CEREBRAL SMALL VESSEL DISEASES
Phase: PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New MRI technique may clear up confusion in aging MS patients
Knowledge-focused Not yet recruitingThis study looks at whether an advanced MRI method called Quantitative Susceptibility Mapping (QSM) can help doctors tell the difference between multiple sclerosis (MS) lesions and age-related white matter changes in people aged 50-70. About 1,000 participants with MS or small ve…
Matched conditions: CEREBRAL SMALL VESSEL DISEASES
Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC